These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9839557)

  • 1. Conserved structural features between HLA-DO beta and -DR beta.
    Thibodeau J; Lavoie PM; Samaan A; Corre JP; Sékaly RP; Cazenave PA
    Mol Immunol; 1998 Sep; 35(13):885-93. PubMed ID: 9839557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimal polymorphism of class II E alpha chains is not due to the functional neutrality of mutations.
    Chu ZT; Carswell-Crumpton C; Cole BC; Jones PP
    Immunogenetics; 1994; 40(1):9-20. PubMed ID: 8206532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
    Mosyak L; Zaller DM; Wiley DC
    Immunity; 1998 Sep; 9(3):377-83. PubMed ID: 9768757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
    Wilkinson D; de Vries RR; Madrigal JA; Lock CB; Morgenstern JP; Trowsdale J; Altmann DM
    J Exp Med; 1988 Apr; 167(4):1442-58. PubMed ID: 3128633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
    J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular distribution of a mixed MHC class II heterodimer between DRalpha and a chimeric DObeta chain.
    Samaan A; Thibodeau J; Mahana W; Castellino F; Cazenave PA; Kindt TJ
    Int Immunol; 1999 Jan; 11(1):99-111. PubMed ID: 10050678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR polymorphism affects the interaction with CD4.
    Fleury S; Thibodeau J; Croteau G; Labrecque N; Aronson HE; Cantin C; Long EO; Sékaly RP
    J Exp Med; 1995 Sep; 182(3):733-41. PubMed ID: 7650480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DO is an intracellular class II molecule with distinctive thymic expression.
    Douek DC; Altmann DM
    Int Immunol; 1997 Mar; 9(3):355-64. PubMed ID: 9088974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
    Moro M; Cecconi V; Martinoli C; Dallegno E; Giabbai B; Degano M; Glaichenhaus N; Protti MP; Dellabona P; Casorati G
    BMC Immunol; 2005 Dec; 6():24. PubMed ID: 16329759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional dissection of the serological DR LYGUE and genotypic DRB1*1303 specificities using a tetanus toxin-specific T-cell clone.
    Martínez-Soria E; Tiercy JM; Beffy P; Taban-Marín P; Jaques D; Bétuel H; Jeannet M; Mach B; Irlé C
    Tissue Antigens; 1993 Sep; 42(3):118-24. PubMed ID: 8284784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the HLA-DM/HLA-DR interface.
    Davies MN; Lamikanra A; Sansom CE; Flower DR; Moss DS; Travers PJ
    Mol Immunol; 2008 Feb; 45(4):1063-70. PubMed ID: 17870168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.